“MEDIscovery, Next-Generation Multi-omics
Platform for Metabolic Disease Drug Discovery”
Technology for identifying key disease targets and discovering therapeutic candidates based on human multi-omics and global clinical big data
A precision medicine development platform that integrates multi-omics data with global clinical big data.
Developing optimized therapies for metabolic diseases is challenging due to individual, ethnic, and regional differences. To advance precision healthcare, MEDI&GENE has developed its proprietary mediscovery platform, integrating clinical big data with multi-omics genomic data to implement optimized therapeutic strategies for targeted individuals and populations.